B
BioNTech
Mainz, Germany
Founded 2008 NASDAQ: BNTX
Nanomedicine Nanovaccines Lipid Nanoparticles mRNA Delivery Cancer Nanotherapy Gene Therapy Delivery
About
Immunotherapy company leveraging lipid nanoparticle delivery for mRNA vaccines and cancer therapies
Company Details
- Type
- commercial
- Employees
- 1000+
- Funding
- Public
Key Products
- Comirnaty COVID-19 Vaccine
- BNT111 Cancer Vaccine